Adnkronos - ultimoratop
Epatocarcinoma avanzato, oncologa Rimassa: "Con immunoterapia Stride 14% vivo a 7 anni"
(Adnkronos) - A Esmo 2026 presentati i nuovi dati dello studio Himalaya
Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.